Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Tovorafenib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 8,560Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 4DAY ONE BIOPHARMS

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    DAY ONE BIOPHARMS

    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    TOVORAFENIB

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    ODE-478
    2031-04-23
    218033
    1
    blank

    01

    DAY ONE BIOPHARMS

    TOVORAFENIB

    arrow
    IPPE
    Not Confirmed

    DAY ONE BIOPHARMS

    U.S.A
    arrow
    IPPE
    Not Confirmed

    TOVORAFENIB

    Exclusivity Code : ODE-478

    Exclusivity Expiration Date : 2031-04-23

    Application Number : 218033

    Product Number : 1

    Exclusivity Details :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    DAY ONE BIOPHARMS

    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    TOVORAFENIB

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    NCE
    2029-04-23
    218033
    1
    blank

    02

    DAY ONE BIOPHARMS

    TOVORAFENIB

    arrow
    IPPE
    Not Confirmed

    DAY ONE BIOPHARMS

    U.S.A
    arrow
    IPPE
    Not Confirmed

    TOVORAFENIB

    Exclusivity Code : NCE

    Exclusivity Expiration Date : 2029-04-23

    Application Number : 218033

    Product Number : 1

    Exclusivity Details :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    DAY ONE BIOPHARMS

    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    TOVORAFENIB

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    ODE-478
    2031-04-23
    217700
    1
    blank

    03

    DAY ONE BIOPHARMS

    TOVORAFENIB

    arrow
    IPPE
    Not Confirmed

    DAY ONE BIOPHARMS

    U.S.A
    arrow
    IPPE
    Not Confirmed

    TOVORAFENIB

    Exclusivity Code : ODE-478

    Exclusivity Expiration Date : 2031-04-23

    Application Number : 217700

    Product Number : 1

    Exclusivity Details :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    DAY ONE BIOPHARMS

    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    TOVORAFENIB

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    NCE
    2029-04-23
    217700
    1
    blank

    04

    DAY ONE BIOPHARMS

    TOVORAFENIB

    arrow
    IPPE
    Not Confirmed

    DAY ONE BIOPHARMS

    U.S.A
    arrow
    IPPE
    Not Confirmed

    TOVORAFENIB

    Exclusivity Code : NCE

    Exclusivity Expiration Date : 2029-04-23

    Application Number : 217700

    Product Number : 1

    Exclusivity Details :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.